238 related articles for article (PubMed ID: 26976570)
1. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
Verma D; Thompson J; Swaminathan S
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3609-14. PubMed ID: 26976570
[TBL] [Abstract][Full Text] [Related]
2. Multiple roles of Epstein-Barr virus SM protein in lytic replication.
Han Z; Marendy E; Wang YD; Yuan J; Sample JT; Swaminathan S
J Virol; 2007 Apr; 81(8):4058-69. PubMed ID: 17287267
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.
Verma D; Church TM; Swaminathan S
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13044-13055. PubMed ID: 32434920
[TBL] [Abstract][Full Text] [Related]
4. Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.
Fu W; Verma D; Burton A; Swaminathan S
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541834
[TBL] [Abstract][Full Text] [Related]
5. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
6. Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency.
Mannemuddhu SS; Xu H; Bleck CKE; Tjandra N; Carter C; Bhaduri-McIntosh S
J Virol; 2021 Jun; 95(13):e0246620. PubMed ID: 33853959
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.
Nicewonger J; Suck G; Bloch D; Swaminathan S
J Virol; 2004 Sep; 78(17):9412-22. PubMed ID: 15308735
[TBL] [Abstract][Full Text] [Related]
8. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
[TBL] [Abstract][Full Text] [Related]
9. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
[TBL] [Abstract][Full Text] [Related]
10. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
[TBL] [Abstract][Full Text] [Related]
11. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
12. Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.
Verma D; Ling C; Johannsen E; Nagaraja T; Swaminathan S
J Virol; 2009 Aug; 83(16):8041-50. PubMed ID: 19515786
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein.
Thompson J; Verma D; Li D; Mosbruger T; Swaminathan S
J Virol; 2016 Feb; 90(3):1206-21. PubMed ID: 26559842
[TBL] [Abstract][Full Text] [Related]
14. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
Huang L; Yang M; Yuan Y; Li X; Kuang E
Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of Epstein-Barr virus SM protein: identification of amino acids essential for structure, transactivation, splicing inhibition, and virion production.
Ruvolo V; Sun L; Howard K; Sung S; Delecluse HJ; Hammerschmidt W; Swaminathan S
J Virol; 2004 Jan; 78(1):340-52. PubMed ID: 14671116
[TBL] [Abstract][Full Text] [Related]
16. Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps.
Keck KM; Moquin SA; He A; Fernandez SG; Somberg JJ; Liu SM; Martinez DM; Miranda JL
J Biol Chem; 2017 Aug; 292(32):13284-13295. PubMed ID: 28588024
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
19. General and target-specific RNA binding properties of Epstein-Barr virus SM posttranscriptional regulatory protein.
Han Z; Verma D; Hilscher C; Dittmer DP; Swaminathan S
J Virol; 2009 Nov; 83(22):11635-44. PubMed ID: 19726500
[TBL] [Abstract][Full Text] [Related]
20. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
Dyson OF; Pagano JS; Whitehurst CB
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]